

High-Risk Beta
This platform is experimental. Smart contracts are unaudited. Use at your own risk.
Former Sen. Ben Sasse is taking Revolution Medicines' daraxonrasib, which has shown promise as a treatment for pancreatic cancer.
Friday, 10 April 2026
Connect your wallet to join the discussion.
No comments yet. Be the first to share your take.